FR2468367B1 - - Google Patents

Info

Publication number
FR2468367B1
FR2468367B1 FR8021107A FR8021107A FR2468367B1 FR 2468367 B1 FR2468367 B1 FR 2468367B1 FR 8021107 A FR8021107 A FR 8021107A FR 8021107 A FR8021107 A FR 8021107A FR 2468367 B1 FR2468367 B1 FR 2468367B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8021107A
Other versions
FR2468367A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of FR2468367A1 publication Critical patent/FR2468367A1/fr
Application granted granted Critical
Publication of FR2468367B1 publication Critical patent/FR2468367B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR8021107A 1979-03-27 1980-10-02 Compositions therapeutiques a base de quinolones Granted FR2468367A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7910558 1979-03-27
GB7939505 1979-11-15

Publications (2)

Publication Number Publication Date
FR2468367A1 FR2468367A1 (fr) 1981-05-08
FR2468367B1 true FR2468367B1 (fr) 1983-09-30

Family

ID=26271029

Family Applications (2)

Application Number Title Priority Date Filing Date
FR8006811A Granted FR2452484A1 (fr) 1979-03-27 1980-03-27 Quinolones, leur procede de preparation et compositions therapeutiques qui les contiennent
FR8021107A Granted FR2468367A1 (fr) 1979-03-27 1980-10-02 Compositions therapeutiques a base de quinolones

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR8006811A Granted FR2452484A1 (fr) 1979-03-27 1980-03-27 Quinolones, leur procede de preparation et compositions therapeutiques qui les contiennent

Country Status (34)

Country Link
US (1) US4302460A (fr)
KR (1) KR840001612B1 (fr)
AT (1) AT379390B (fr)
AU (1) AU536616B2 (fr)
BG (2) BG37836A3 (fr)
CA (1) CA1151652A (fr)
CH (1) CH644366A5 (fr)
CS (1) CS221906B2 (fr)
DD (1) DD149608A5 (fr)
DE (2) DE3051205C2 (fr)
DK (1) DK151252C (fr)
EG (1) EG16606A (fr)
FI (1) FI77026C (fr)
FR (2) FR2452484A1 (fr)
GR (1) GR68007B (fr)
HK (1) HK94986A (fr)
HU (1) HU179845B (fr)
IE (1) IE49562B1 (fr)
IL (1) IL59710A (fr)
IT (1) IT1188916B (fr)
KE (1) KE3649D (fr)
LU (1) LU82295A1 (fr)
MX (1) MX6816E (fr)
MY (1) MY8600668A (fr)
NL (1) NL191306C (fr)
NO (1) NO156787C (fr)
NZ (1) NZ193167A (fr)
PH (1) PH16758A (fr)
PL (1) PL124037B1 (fr)
PT (1) PT71006A (fr)
RO (1) RO79397A (fr)
SE (1) SE455422B (fr)
SG (1) SG60886G (fr)
YU (1) YU42332B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
EP0149519B1 (fr) * 1984-01-13 1990-06-27 The Boots Company PLC Utilisation de quinolones pour la fabrication d'une composition pour le traitement de maladies cardiaques.
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
GB8918952D0 (en) * 1989-08-19 1989-10-04 Boots Co Plc Therapeutic agents
FR2680511B1 (fr) * 1991-08-20 1995-05-19 Roussel Uclaf Derives n-substitues de la quinoleine, leur procede de preparation, intermediaires obtenus, leur application comme medicaments et les compositions les renfermant.
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
FR2684671B1 (fr) * 1991-11-20 1995-05-19 Roussel Uclaf Nouveaux derives de la quinoleine, leur procede de preparation et intermediaires et leur application a titre de medicaments.
FR2672597B1 (fr) * 1991-02-07 1995-05-19 Roussel Uclaf Nouveaux derives n-substitues de la quinoleine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
WO2000007595A1 (fr) * 1998-08-03 2000-02-17 Basf Corporation Utilisation de pyridinones pour traiter les dysfonctionnements sexuels
US6307050B1 (en) * 2000-08-29 2001-10-23 R. T. Alamo Venture I Llc Method of synthesizing flosequinan from 4-fluoroanthranilic acid
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6649764B2 (en) * 2001-10-25 2003-11-18 R. T. Alamo Ventures I, Llc Stereospecific enrichment of heterocyclic enantiomers
US6730790B2 (en) * 2002-03-01 2004-05-04 R.T. Alamo Ventures I. Llc Chlorinated heterocyclic compounds and methods of synthesis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178348A (en) * 1961-02-08 1965-04-13 Norwich Pharma Co Hypotensive quinolines
GB1066919A (en) 1964-04-03 1967-04-26 Hoffmann La Roche Novel benzyl amine derivatives
DE1770482A1 (de) * 1968-05-22 1971-11-11 Basf Ag Verfahren zur Herstellung von 2,4-Dioxychinolinen
US3798219A (en) * 1971-10-18 1974-03-19 Warner Lambert Co 3-(methylsulfinyl)cinnolinones and their derivatives
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils
CH607848A5 (fr) * 1974-06-04 1978-11-30 Bayer Ag
GB1488411A (en) * 1975-01-16 1977-10-12 Wyeth John & Brother Ltd 3,4-dihydro-4-arylquinolin-4-ol derivatives
US4127574A (en) * 1976-03-01 1978-11-28 Sandoz, Inc. 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones
US4124587A (en) * 1976-03-01 1978-11-07 Sandoz, Inc. 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones
DE2616995A1 (de) 1976-04-17 1977-10-27 Bayer Ag 1.4-dihydropyridine mit schwefelhaltigen substituenten mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2616991A1 (de) 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2639257A1 (de) 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2639498A1 (de) 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2641746C2 (de) 1976-09-16 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-Zuckerderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2658183A1 (de) 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658804A1 (de) 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
US4177278A (en) * 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
DE2715182A1 (de) 1977-04-05 1978-10-19 Bayer Ag 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5424882A (en) 1977-07-22 1979-02-24 Yamanouchi Pharmaceut Co Ltd Novel heterocyclic compounds and their preparation
DE2747513A1 (de) 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen

Also Published As

Publication number Publication date
IT8048262A1 (it) 1981-09-26
NL8001771A (nl) 1980-09-30
DE3011994C2 (fr) 1991-06-27
DE3011994A1 (de) 1980-10-16
NL191306B (nl) 1994-12-16
KE3649D (en) 1986-08-01
HU179845B (en) 1982-12-28
KR830001898A (ko) 1983-05-19
CS221906B2 (en) 1983-04-29
FI800923A (fi) 1980-09-28
DE3051205C2 (de) 1991-01-24
YU42332B (en) 1988-08-31
IE49562B1 (en) 1985-10-30
HK94986A (en) 1986-12-12
BG37836A3 (en) 1985-08-15
MY8600668A (en) 1986-12-31
AU536616B2 (en) 1984-05-17
AU5670280A (en) 1980-10-02
NO800881L (no) 1980-09-29
DK151252B (da) 1987-11-16
DK151252C (da) 1988-05-16
FI77026C (fi) 1989-01-10
MX6816E (es) 1986-08-05
PH16758A (en) 1984-02-15
RO79397A (fr) 1982-06-25
IL59710A (en) 1984-01-31
SE8002345L (sv) 1980-11-14
YU84980A (en) 1983-09-30
FR2452484B1 (fr) 1983-08-12
CA1151652A (fr) 1983-08-09
NO156787C (no) 1987-11-25
PT71006A (en) 1980-04-01
IE800567L (en) 1980-09-27
FR2468367A1 (fr) 1981-05-08
FI77026B (fi) 1988-09-30
US4302460A (en) 1981-11-24
IT8048262A0 (it) 1980-03-26
DD149608A5 (de) 1981-07-22
NL191306C (nl) 1995-05-16
GR68007B (fr) 1981-10-26
SG60886G (en) 1987-03-27
AT379390B (de) 1985-12-27
PL124037B1 (en) 1982-12-31
PL223050A1 (fr) 1981-01-30
LU82295A1 (fr) 1981-04-17
FR2452484A1 (fr) 1980-10-24
KR840001612B1 (ko) 1984-10-11
IT1188916B (it) 1988-01-28
EG16606A (en) 1989-01-30
SE455422B (sv) 1988-07-11
NO156787B (no) 1987-08-17
ATA161880A (de) 1985-05-15
BG37993A3 (en) 1985-09-16
NZ193167A (en) 1984-08-24
DK130180A (da) 1980-09-28
CH644366A5 (fr) 1984-07-31

Similar Documents

Publication Publication Date Title
FR2447246B1 (fr)
FR2447856B1 (fr)
FR2448130B1 (fr)
BR8002583A (fr)
FR2452484B1 (fr)
FR2447643B3 (fr)
BR8006808A (fr)
FR2446202B3 (fr)
FR2446848B1 (fr)
FR2447152B1 (fr)
FR2446328B1 (fr)
DE2950934C2 (fr)
FR2447463B1 (fr)
FR2446894B1 (fr)
DE2926580C2 (fr)
FR2447476B1 (fr)
DE2915307C2 (fr)
AT364253B (fr)
AU78386S (fr)
AU78271S (fr)
AU78390S (fr)
AU77763S (fr)
AU79557S (fr)
AU77669S (fr)
AU78385S (fr)